Betadine, Sore Throat Spray, 50 mL

Betadine Sore Throat Spray is a 50 mL antiseptic throat spray containing 0.45% povidone-iodine (PVP-I) as the active ingredient. Povidone-iodine is a broad-spectrum antimicrobial that simultaneously disrupts the cell walls, lipid membranes, and metabolic pathways of bacteria, viruses, and fungi — a multi-target mechanism of action that makes it extremely difficult for pathogens to develop resistance. The spray is used by directing it to the back of the throat, where it acts quickly to kill the majority of bacteria and viruses responsible for sore throats and sore throat symptoms. Laboratory testing confirmed by the University of Malaya's Tropical Infectious Diseases Research and Education Centre (TIDREC) demonstrated that Betadine products kill 99.99% of the SARS-CoV-2 virus in 15 seconds. The formulation also contains glycerin to soothe the mucous membrane and mint for a cooling sensation. Betadine is the registered brand name for PVP-I owned by Mundipharma, a German pharmaceutical group, and has been trusted in hospitals worldwide for over 60 years.

Betadine Sore Throat Spray has documented efficacy against a wide range of pathogens including Gram-positive and Gram-negative bacteria, enveloped and non-enveloped viruses, and fungi. The active ingredient PVP-I kills antibiotic-resistant bacterial strains — an important distinction from antibiotic treatments. On the viral side, published research demonstrates PVP-I activity against rhinovirus and influenza viruses, both common causes of throat irritation and upper respiratory infections. The TIDREC laboratory study published in the British Dental Journal confirmed that Betadine solutions neutralized SARS-CoV-2 (the COVID-19 virus) at 99.99% within 15 seconds in vitro. Betadine's history includes being used by hospitals globally during MERS and SARS outbreaks and being selected by NASA for decontamination of the Apollo 11 capsule in 1969. This combination of bacterial, viral, and fungal coverage makes it relevant for throat discomfort of various microbial origins — not only bacterial infections for which antibiotics are prescribed.

Betadine Sore Throat Spray is approved for use by adults and children aged 6 and over. The recommended dose is to spray directly onto the back of the throat as needed, every 3 to 4 hours, up to a maximum of 3 times per day. It should not be swallowed in large amounts; incidental small swallowing is generally not harmful, but if a significant amount is accidentally ingested, medical attention should be sought immediately. It should not be used by individuals who are allergic to any ingredient, those with any type of thyroid disease, and women who are pregnant or breastfeeding. It should not be used at the same time as hydrogen peroxide products, as the two can interact. The product may discolor dentures or braces — these should be removed before use where possible. Avoid contact with jewelry, especially silver. If allergic reactions such as redness, inflammation, swelling, itching, or rash occur, discontinue use and seek medical care immediately.

Most throat sprays and lozenges available in pharmacies rely on local anesthetics such as benzocaine or phenol to temporarily numb pain, or on menthol and glycerin to soothe irritation — they do not actively kill the bacteria or viruses causing the throat infection. Betadine Sore Throat Spray is one of the few non-prescription throat products with a documented direct antimicrobial mechanism: PVP-I physically destroys pathogens rather than masking symptoms. This distinction is meaningful for throat discomfort caused by an actual infection rather than environmental irritation. Betadine is also one of the only throat products with published antiviral activity data specifically against coronaviruses, rhinoviruses, and influenza — not just bacteria. As a Mundipharma-registered pharmaceutical, Betadine undergoes rigorous pharmaceutical-grade quality controls that are above the standard for most OTC throat sprays. The compact 50 mL bottle with a pump cap design provides consistent, targeted dosing compared to lozenges, where active ingredient concentration varies as the lozenge dissolves.

Betadine is a trusted antiseptic brand with over 50 years of hospital use worldwide, owned by Purdue Pharma. Its active ingredient is povidone-iodine -- a complex of iodine and polyvinylpyrrolidone (PVP) -- which delivers broad-spectrum antimicrobial action against bacteria, viruses, fungi, and some spores. In Canada, Betadine holds Health Canada NPN 00158291 (1% povidone-iodine Sore Throat Gargle) and is available in multiple formats: sore throat spray (0.45%), gargle (1%), nasal spray, and topical wound solution (5%). The sore throat gargle is approved for adults and children aged 9 and older, up to 4 times daily.

Betadine's key distinction is its regulatory classification and mechanism of action. Unlike Dettol (chlorhexidine or chloroxylenol-based) and Listerine (ethanol and essential oils), Betadine uses povidone-iodine -- a molecule that simultaneously disrupts microbial cell proteins, fatty acids, and membranes, rather than targeting a single pathway. This multi-target action makes pathogen resistance harder to develop. Betadine's sore throat formulations are licensed by Health Canada with specific antiseptic health claims, while mouthwash brands are typically regulated only as cosmetics. Research also confirms Betadine's efficacy against rhinoviruses and influenza viruses, extending its use to respiratory mucosa protection.